✦ LIBER ✦

p53Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer

✍ Scribed by U. Vogt; A. Zaczek; F. Klinke; A. Granetzny; K. Bielawski; B. Falkiewicz

Publisher: Springer-Verlag
Year: 2002
Tongue: English
Weight: 95 KB
Volume: 128
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-001-0305-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p53tumour-suppressor gene in non-small-c

p53tumour-suppressor gene in non-small-cell lung cancer with neoadjuvant therapy

✍ K. Junker; T. Wiethege; K.-M. Müller; M. Thomas 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 184 KB

Thallium-201 SPECT in advanced non-small

Thallium-201 SPECT in advanced non-small cell lung cancer: In relation with chemotherapeutic response, survival, distant metastasis and p53 status

✍ Tevfik Fikret Çermik; Mahmut Yüksel; Celal Karlikaya; Latife Doĝanay; Mevlüt Tür 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 760 KB

Induction of tubulin by docetaxel is ass

Induction of tubulin by docetaxel is associated with p53 status in human non small cell lung cancer cell lines

✍ Jinghua Tsai Chang; Gee-Chen Chang; Jiunn-Liang Ko; Hung-Ya Liao; Hsin-Ju Liu; C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 408 KB 👁 1 views

Docetaxel (DOC), a member of the taxane family of anticancer drugs, binds to tubulin and produces unnaturally stable microtubules that induce cell death. DOC is used clinically alone or in combination with other compounds to treat advanced stages of cancer. We have treated the human lung cancer cell

Regulation of chemosensitivity and migra

Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells

✍ Ching-Yuan Cheng; Shur-Hueih Cherng; Wen-Jun Wu; Tsung-Ying Yang; Xin-Yi Huang; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 547 KB

Immunohistochemical p53 protein status i

Immunohistochemical p53 protein status in nonsmall cell lung cancer is a promising indicator in determining in vitro chemosensitivity to some anticancer drugs

✍ Higashiyama, Masahiki; Kodama, Ken; Yokouchi, Hideoki; Takami, Koji; Doi, Osamu; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Background and Objectives: The tumor suppressor oncogene p53 abnormalities have been closely associated with resistance or sensitivity of cancer cells to some chemotherapeutic agents. We examined the association between p53 protein status in nonsmall cell lung cancer (NSCLC) and in vitro chemos

Analysis of p53 mutations in histologica

Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non-small cell lung cancer patients

✍ Weimin Gao; Hussam H. Mady; Mona F. Melhem; Phouthone Keohavong 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

## Abstract Our previous study showed a characteristic p53 mutational spectrum in lung tumors from lung cancer patients in the Western Pennsylvania region. To further understand the involvement of p53 mutations in lung tumor development, in this study we compared p53 mutational spectra and distribu